Pathology Reporting in Breast Cancer Screening (2nd edition) |
![]() |
|
|
ISBN 1 871997 22 4 Specimens from screened women provide the pathologist with particular problems of macroscopic and histological examination; the former principally result from identifying impalpable radiological abnormalities and the latter from classifying borderline lesions which are encountered with disproportionate frequency. Accurate pathological diagnoses and the provision of prognostically significant information are important to ensure that patients are managed appropriately and that the programme is properly monitored and evaluated. The standard set of data from each patient using the same terminology and diagnostic criteria is essential to achieve the latter objectives. National Coordinating Group for Breast Screening Pathology. NHSBSP Publication No 3. Revised February 1997. Copies of NHSBSP publications are normally free of charge for staff working within the NHS, the voluntary sector and for healthcare students. To order copies or obtain details of prices and availability of publications to those outside the NHS, please contact the Department of Health publication orderline: Telephone: 0300 123 1002, Textphone: 0300 123 1003, Fax: 01623 724 524, Email orders: [email protected] |
Breast screening programme index What happens at a What are the risks of breast screening? Frequently Asked Questions (FAQs) DCIS (Ductal Carcinoma |
||||||||
|
||||||||||